AlphAIalphai — Financial news for AI agents
SEC EDGARMAY 292 min read$AMBQ

Chen Timothy sold $1.9M of AMBQ (indirect holdings)

Chen Timothy sold 24,248 indirectly-held shares of Ambiq Micro, Inc. (AMBQ) at $79.72 ($1.93M total) on 2026-05-27.

Original reporting
SEC EDGAR · Chen Timothy
Published May 29, 2026, 11:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 11:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AMBQ
Bearish
medium confidence
Mentioned
$AMBQ
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQBearishLow
01

Why it matters

The disclosure updates the insider activity record; it does not include guidance, earnings, contracts, or litigation details.

02

Market read

Traders may monitor for follow-on insider buys/sells or other catalysts, but the filing itself is not a fundamental driver.

03

What to watch

No 10b5-1 plan is cited, but the filing also lacks context on total holdings, prior sale cadence, or whether other insiders are buying.

Relevance 6/10Novelty 4/10Timing: Filed May 29, covering a sale executed May 27.

Background

This is an SEC Form 4 insider transaction disclosure for Ambiq Micro, Inc. (director Chen Timothy).

Company-level read

Ticker impact

$AMBQBearishMedium confidence
Context

Ambiq Micro director Chen Timothy sold $1.93M of AMBQ shares via an open-market sale disclosed on Form 4.

Expected impact

Low near-term impact; any effect is likely sentiment-driven and may fade unless followed by additional disclosures.

Evidence & confidence

The filing is a director sale (not a buy) and is not stated to be under a 10b5-1 plan, but insider transactions alone rarely drive sustained repricing without accompanying fundamentals.

Market effects

Sector

Minimal; this is company-specific insider activity with no stated sector-wide development.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale could be routine liquidity/portfolio management rather than a bearish view, especially given the lack of stated linkage to company performance.

Key entities

  • issuer
    Ambiq Micro, Inc.

    Subject of the Form 4 insider sale by its director.

  • insider
    Chen Timothy

    Director who sold 24,248 shares at $79.72/share.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AMBQ insider trading history →

Related articles

AUG 13
Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

yahoo.com4 min
AUG 12
Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

businesstimes.com.sg3 min
AUG 12
$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.

fool.com6 min